Investors present two short, five long ideas at Delivering Alpha

Alex Denner’s Sarissa has made outsize gains from biotechnology investments this year.

One River down double digits in systematic fund

February’s sharp reversal set the firm on a downward trend.

Citadel’s Griffin sees risks in Italy-EU relations

Griffin said the firm is monitoring its investments in the region given political uncertainties.

Citadel’s Griffin sees risks in Italy-EU relations

Griffin said the firm is monitoring its investments in the region given political uncertainties.

Upstart quantitative manager Tenacis suffers performance drop

Backed originally by Leucadia Asset Management, the firm raised more than $100 million this year.

Light Street continues performance hot streak

Similar funds focusing on emerging technologies also posted some of the highest returns through June.



Asset flows: Investors favor debt strategies in May

Hedge funds attracted new capital for the second straight month.


CRTs: building for a fall?

CRT investors question whether they are adequately compensated for idiosyncratic risks.

SPAC boom shows no signs of slowing down

Hedge funds are back to embracing one of their favorite trades, is this time different?